News

Johnson & Johnson Restructures Its Dengue Treatment Initiatives

Johnson & Johnson Restructures Its Dengue Treatment Initiatives

Johnson & Johnson Discontinues Phase 2 Study

Recently, Johnson & Johnson announced it has decided to discontinue its Phase 2 field study aimed at evaluating the efficacy of an investigational antiviral, mosnodenvir. This candidate was intended to help prevent dengue virus infections in adults aged 18 to 65. The decision reflects a strategic shift within the company’s research and development focus.

Strategic Reprioritization of R&D

This shift in direction indicates a reallocation of resources within the company’s Communicable Diseases research portfolio, rather than any safety concerns tied to the study. Researchers are currently working on final data analyses from the Phase 2 study, and the efficacy data will be shared once these analyses are completed.

Insights from Previous Studies

Mosnodenvir, previously known as JNJ-1802, has been found to be safe and well-tolerated based on earlier Phase 1 and Phase 2a clinical trials. Results from a recent Phase 2a human challenge study demonstrated promising antiviral activity against dengue (DENV-3) in participants when compared to a placebo group.

Details from the Phase 2a Study

The Phase 2a study evaluated various dosing regimens of JNJ-1802 against an attenuated strain of dengue (DENV-3) in healthy volunteers. Participants received daily doses of either the antiviral or a placebo over a 26-day period, during which they were intentionally exposed to DENV-3 on the 5th day. Monitoring continued for 85 days, revealing a dose-dependent effect on the RNA levels of DENV-3 in participants.

Recent Developments in Dengue Vaccines

Meanwhile, in the broader context of dengue prevention, in May, Takeda Pharmaceutical Co Ltd received World Health Organization (WHO) prequalification for its dengue vaccine, TAK-003. This marks it as the second dengue vaccine to attain WHO prequalification.

Recommendations for Dengue Vaccination

WHO has recommended that TAK-003 be administered to children aged 6 to 16 years in regions experiencing high dengue burden and transmission intensity. These developments highlight the ongoing efforts to combat the dengue virus effectively.

Current Stock Price Impact

As of the latest trading session, JNJ stock has experienced a 0.60% decrease, resting at $159.53. Observers will be keen to see how this decision affects the company's stock performance in the coming days.

Looking Ahead

While Johnson & Johnson steps back from its dengue antiviral study, it continues to analyze data from prior trials, which could inform future strategies in treating and preventing infectious diseases.

Frequently Asked Questions

What was the reason for discontinuing the Phase 2 study?

Johnson & Johnson has decided to discontinue the study as part of a strategic reprioritization within its research and development portfolio, not due to safety concerns.

What is mosnodenvir?

Mosnodenvir is an investigational antiviral candidate developed by Johnson & Johnson, previously known as JNJ-1802, aimed at preventing dengue virus infections.

What has been the outcome of previous studies on mosnodenvir?

Earlier studies indicated that mosnodenvir is safe and well-tolerated, with recent trials showing promising antiviral activity against the dengue virus.

What is the status of other dengue vaccines?

In addition to Johnson & Johnson's efforts, Takeda's TAK-003 vaccine has received WHO prequalification, making significant strides in the fight against dengue.

How has the stock of Johnson & Johnson reacted to this news?

Following the announcement, JNJ stock noted a minor decline of 0.60%, which reflects investor sentiment regarding the shift in research priorities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 0

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 0

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 1

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 3

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 2

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 3

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 8

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Fenix24 and Partners Recognized for Outstanding Cybersecurity

Updated Category News Views 306

Fenix24 and Partners Shine in Global Cybersecurity Awards Fenix24, a leading cyber disaster recovery firm, has affirmed its position as a market leader following recent recognitions in the cybersecurity sector. This award from the Cyber Defense Magazine showcases Fenix24’s commitment to setting new standards in breach recovery and incident response, fostering...

Continue Reading
Savara Inc. Shareholders: Your Chance to Join the Legal Battle

Updated Category News Views 207

Understanding the Opportunity for Action Investors holding shares of Savara Inc. (NASDAQ: SVRA) may find an important opportunity to engage in a class action lawsuit. The law firm spearheading this effort, known for its focus on shareholder rights, is reaching out to those affected by possible misstatements made by the company. What Led to the Class Action Lawsuit? The...

Continue Reading
Brennan Investment Group Expands Portfolio with Major Acquisition

Updated Category News Views 415

Brennan Investment Group's Strategic Move in the Industrial Market Brennan Investment Group has made a significant stride in the industrial real estate sector with its recent acquisition of an expansive industrial campus previously owned by Innovex. This strategic move marks one of the largest transactions in the region this year, emphasizing the group's commitment to...

Continue Reading
ViaSat Faces Competition From Starlink in Connectivity Market

Updated Category News Views 240

ViaSat's Position in the Market Amid Starlink's Rise Deutsche Bank recently reaffirmed its Hold rating on ViaSat (NASDAQ: VSAT), setting a target price of $22. This update comes after noticeable shifts in the inflight connectivity market, particularly with Starlink emerging as a formidable competitor by securing contracts for about 2,500 aircraft, which includes both...

Continue Reading
Stellantis NV: Short Interest Shift Sparks Investor Sentiment Questions

Updated Category News Views 231

Stellantis NV's (NYSE:STLA) short interest saw a notable drop of 13.81% since its last report, now standing at 44.96 million shares sold short, or about 1.56% of all tradable shares. Sounds like good news, right? But hang on—this isn't just a free pass to pop the champagne. When we talk short interest, we're peeling back layers on market sentiment that can turn on a...

Continue Reading